Genomma Lab Internacional S.A.B. de C.V

Research Genomma Lab Internacional S.A.B. de C.V (GEKA) on Bullrun: market cap EUR 650.21M, P/E 8.3, dividend yield 6.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 650.21M; P/E is 8.3; dividend yield is 6.0%.

Peer valuation comparison

Latest P/E is 8.31x versus a Healthcare sector median of 24.46x (66.0% below).

Latest dividend yield is 6.01% versus a Healthcare sector median of 2.11% (184.8% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-28EUR 650.21M8.36.0%0.04

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.04 EUR, yield 6.0%.

YearDividends/share
FY20250.04 MXN

About Genomma Lab Internacional S.A.B. de C.V

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Genomma Lab Internacional S.A.B. de C.V's market cap?

Genomma Lab Internacional S.A.B. de C.V's market capitalization is EUR 650.21M.

What is Genomma Lab Internacional S.A.B. de C.V's P/E ratio?

Genomma Lab Internacional S.A.B. de C.V's price-to-earnings (P/E) ratio is 8.3.

Does Genomma Lab Internacional S.A.B. de C.V pay a dividend?

Genomma Lab Internacional S.A.B. de C.V has a dividend yield of 6.0%.

What does Genomma Lab Internacional S.A.B. de C.V do?

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally.